Cerecin

About:

Cerecin is a healthcare company that develops a novel evidence-based therapeutics and products that aim to help people.

Top Investors: KB Financial Group, Partners Investment, M Capital Partners, Shinhan Investment, IBK Capital

Description:

Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people. Cerecin develops novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastating neurological diseases. The company was founded in 2001 and is based in Denver, Colorado.

Total Funding Amount:

$77.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Denver, Colorado, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)cerecin.com

Founders:

Mark Heiman, Samuel Henderson, Steve Orndorff

Number of Employees:

11-50

Last Funding Date:

2022-09-28

IPO Status:

Private

Industries: